Technical Analysis for ABIO - ARCA biopharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 3.80 | -0.78% | -0.03 |
ABIO closed down 0.78 percent on Monday, July 1, 2024, on 19 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Jul 19
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | -0.78% | |
| Above Upper BB | Strength | -0.78% | |
| Overbought Stochastic | Strength | -0.78% | |
| Upper Bollinger Band Touch | Strength | -0.78% | |
| 20 DMA Support | Bullish | 5.56% | |
| 50 DMA Support | Bullish | 5.56% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | 5.56% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 7 hours ago |
| Down 3% | about 7 hours ago |
| Down 2 % | about 7 hours ago |
| Down 1% | about 7 hours ago |
| Fell Below Upper Bollinger Band | about 7 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 07/19/2024
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cardiovascular Disease Heart Failure Vascular Disease Dysfunction Heart Disease Cardiac Arrhythmia Atrial Fibrillation Ventricular Dysfunction
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cardiovascular Disease Heart Failure Vascular Disease Dysfunction Heart Disease Cardiac Arrhythmia Atrial Fibrillation Ventricular Dysfunction
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.49 |
| 52 Week Low | 1.56 |
| Average Volume | 107,759 |
| 200-Day Moving Average | 2.28 |
| 50-Day Moving Average | 3.43 |
| 20-Day Moving Average | 3.43 |
| 10-Day Moving Average | 3.51 |
| Average True Range | 0.25 |
| RSI (14) | 63.10 |
| ADX | 13.19 |
| +DI | 21.68 |
| -DI | 22.62 |
| Chandelier Exit (Long, 3 ATRs) | 3.31 |
| Chandelier Exit (Short, 3 ATRs) | 3.66 |
| Upper Bollinger Bands | 3.81 |
| Lower Bollinger Band | 3.06 |
| Percent B (%b) | 0.99 |
| BandWidth | 21.70 |
| MACD Line | 0.09 |
| MACD Signal Line | 0.05 |
| MACD Histogram | 0.0457 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.07 | ||||
| Resistance 3 (R3) | 4.06 | 3.95 | 4.03 | ||
| Resistance 2 (R2) | 3.95 | 3.88 | 3.96 | 4.01 | |
| Resistance 1 (R1) | 3.88 | 3.84 | 3.83 | 3.89 | 3.99 |
| Pivot Point | 3.77 | 3.77 | 3.75 | 3.78 | 3.77 |
| Support 1 (S1) | 3.70 | 3.70 | 3.65 | 3.71 | 3.61 |
| Support 2 (S2) | 3.59 | 3.66 | 3.60 | 3.59 | |
| Support 3 (S3) | 3.52 | 3.59 | 3.58 | ||
| Support 4 (S4) | 3.53 |
